BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3556373)

  • 1. Three months energy restricted diet does not reduce peripheral insulin resistance in newly diagnosed non insulin dependent diabetics.
    Walshe K; Andrews WJ; Sheridan B; Woods R; Hadden DR
    Horm Metab Res; 1987 May; 19(5):197-200. PubMed ID: 3556373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
    Sindelka G; Skrha J; Hilgertová J; Justová V
    Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.
    Boyd K; Boreham C; Andrews WJ; Hadden DR
    Diabetes Res; 1991 Nov; 18(3):101-8. PubMed ID: 1841819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
    Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
    Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
    Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin modulates early-phase noradrenaline response to glucose ingestion in humans.
    Koh H; Waki M; Nambu S
    Horm Metab Res; 1988 May; 20(5):282-7. PubMed ID: 3042578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus.
    Wolffenbuttel BH; Weber RF; Van Koetsveld PM; Verschoor L
    Int J Obes; 1989; 13(2):173-82. PubMed ID: 2744929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.
    Henry RR; Scheaffer L; Olefsky JM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):917-25. PubMed ID: 4044780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.
    Bratusch-Marrain PR; Vierhapper H; Komjati M; Waldhäusl WK
    Diabetologia; 1985 Sep; 28(9):671-6. PubMed ID: 3905478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus.
    Hother-Nielsen O; Beck-Nielsen H
    Acta Endocrinol (Copenh); 1991 Jun; 124(6):637-45. PubMed ID: 2068893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity.
    Hosker JP; Kumar S; Gordon C; Bhatnagar D; France M; Boulton AJ
    Diabet Med; 1993 Jul; 10(6):509-13. PubMed ID: 8365085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin action in obese non-insulin-dependent diabetics and in their isolated adipocytes before and after weight loss.
    Zawadzki JK; Bogardus C; Foley JE
    Diabetes; 1987 Feb; 36(2):227-36. PubMed ID: 3542647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of VLCD in obese NIDDM (non-insulin dependent diabetes) on glucose, insulin and C-peptide dynamics.
    Weck M; Hanefeld M; Schollberg K
    Int J Obes; 1989; 13 Suppl 2():159-60. PubMed ID: 2693380
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients.
    Paolisso G; D'Amore A; Giugliano D; Ceriello A; Varricchio M; D'Onofrio F
    Am J Clin Nutr; 1993 May; 57(5):650-6. PubMed ID: 8480681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.